Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
They are pre-dosed, meaning each troche contains a fixed milligram amount
Clinical-trial references for FDA-approved GLP-1 or GLP-1/GIP medications shouldn't be read as proof that Telos Rx's own compounded formulations have been independently studied, FDA-reviewed, or shown to produce the same outcomes
Weight loss with Tirzepatide is gradual, and continued usealongside healthy lifestyle habitsis necessary to maintain your progress
Many patients describe a clear rhythm: Days 12: The strongest side effects (nausea, fatigue, profound appetite suppression)
Understanding the compounded tirzepatide starting dose that is right for your situation is part of this consultation